Treatment of chronic myelogenous leukemia
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='450' side='right' scene='Imatinib/Imatinib/2' caption='Imatinib, also known as Gleevec ([[2hyy]])' pspeed='8'> | <StructureSection load='' size='450' side='right' scene='Imatinib/Imatinib/2' caption='Imatinib, also known as Gleevec ([[2hyy]])' pspeed='8'> | ||
*[[Imatinib]] | *[[Imatinib]] | ||
| - | + | *[[Nilotinib]] | |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:10, 20 February 2024
| |||||||||||
